BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 103 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $249,000 | -61.9% | 1,706 | -63.7% | 0.00% | -71.4% |
| Q3 2021 | $653,000 | +12.2% | 4,700 | -21.7% | 0.01% | +16.7% |
| Q2 2021 | $582,000 | -33.8% | 6,000 | -55.6% | 0.01% | -64.7% |
| Q3 2020 | $879,000 | +42.0% | 13,525 | +19.0% | 0.02% | +13.3% |
| Q4 2019 | $619,000 | -84.6% | 11,361 | -88.2% | 0.02% | -87.3% |
| Q3 2019 | $4,026,000 | +1543.3% | 96,500 | +1623.2% | 0.12% | +1211.1% |
| Q2 2019 | $245,000 | -55.1% | 5,600 | -47.2% | 0.01% | -52.6% |
| Q1 2019 | $546,000 | -92.3% | 10,600 | -94.5% | 0.02% | -93.1% |
| Q4 2018 | $7,123,000 | +97.0% | 192,600 | +100.0% | 0.27% | +70.2% |
| Q3 2018 | $3,616,000 | +19.0% | 96,300 | -18.3% | 0.16% | -29.4% |
| Q1 2018 | $3,038,000 | +426.5% | 117,919 | +451.2% | 0.23% | +385.1% |
| Q4 2017 | $577,000 | – | 21,394 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |